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Abstract: Eighty Wistar rats were divided into 4 groups and examined over a 
period of 2 or 8 weeks. First, a surgical defect was created in the calvaria 
using a 6 mm diameter trephine drill. The cavity was then treated with BCP 
(biphasic calcium phosphate), MTA, or the combination of the two. In the 
control, the cavity was allowed to clot. After 2 or 8 weeks, animals were 
sacrificed and the bones were subjected to a histological evaluation and 
immunohistochemical staining to evaluate areas of new osteoid tissue and 
new bone tissue as well as the percentage of labeled cells that utilize anti-
BMPR1B antibodies. Twoway ANOVA showed statistical significant diference in 
all dependent variable (area of new osteoid tissue; area of new bone and % 
of immunostainning) within group p=0.00000, time p=0.00000 and with the 
interaction of both p=0.0000. MTA group at 8 weeks showed the highest 
amount of osteoid tissue (6.25 ± 0.30 mm2). The same group also exhibited 
the highest amount of bone tissue formation (3.98 ± 0.14 mm2). In contrast, 
both 2-week MTA samples (40.73 ± 2.50%) and 2-week BCP+MTA samples 
(40.30 ± 1.81%) exhibited the highest percentage of stained cells. Best 
results in terms of the area of osteoid and bone tissue formation and the 
percentage of BMPR1B markings were observed for the MTA group, 
confirming that the combination of BCP and MTA does not result in a 
significant improvement. 
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Introduction 
 
Mineral Trioxide Aggregate (MTA) is a biocompatible material18 
and can help in bone repair because its composition provides rapid 
accession and proliferation cell on its structure6,10. There is evidence 
that MTA promotes a favorable response in osseous environment, with 
direct bone apposition30. It was demonstrated that MTA induces bone 
morphogenetic protein 2 expression and calcification in human 
periodontal ligament cells20 and stimulating human gingival fibroblasts 
to produce BMP-214, is able to promote a favorable formation of 
mineralized tissue in rat alveolar sockets15, being characterized by mild 
inflammatory response and complete bone healing16. MTA surfaces 
also support osteoblast cell attachment, matrix synthesis and RunX2 
expression which are essential for osteogenesis24. 
 
The use of biphasic calcium phosphate (BCP) in orthopaedic and 
in oral surgeries as an osteoconductive material has proven to be 
effective in promoting bone healing. In addition, BCP is considered to 
be a safe biomaterial and exhibits high bio-compatibility.7,8,26 The 
structure of biphasic calcium phosphate consists of particles with an 
average size of 100-500 μm composed of 60% hydroxyapatite and 
40% of tricalcium beta-phosphate (b-TCP).7  
 
Compounds based on HA exhibit a low or negligible 
bioabsorbtivity whereas those based on β-TCP are more soluble and 
can be easily degraded or reabsorbed. At the same time, β-TCP is 
unpredictable and thus are not an appropriate scaffold for bone 
growth. The association between HA and β-TCP generates a 
biomaterial called BCP, which is re-absorbable but also contains a 
more stable segment (HA) that maintains the stability of the scaffold, 
the graft and the more soluble component (β-TCP).7,27 
 
Immunohistochemical analyses and in situ hybridization 
experiments have been used to reveal that mesenchymal cells, 
including osteoblasts, express morphogenetic bone proteins (BMP) and 
receptors (BMPR) during the formation of skeletal and fracture repair 
bone tissue.2,17 These glycoproteins are responsible for bringing 
osteoprogenitor cells to bone formation and repair sites and thus have 
important implications in cascades of cellular events that regulate bone 
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formation and repair. During these processes, mesenchymal cells 
induce cell proliferation and differentiation, and promote the synthesis 
of the extracellular matrix.1,3,17 As a result, BMPs are involved in the 
differentiation process wherein osteoprogenitor cells transform into 
mature osteoblasts.32,33 
 
The cellular response to BMP depends not only on the 
expression of type of protein but also of the expression and location of 
the surface transmembrane receptors BMPR type 1A, 1B, and type 2.28 
In the calvaria, where it is possible to observe intramembranous 
ossification, the signal for a reparable or formative process is regulated 
by the BMPR-1B receptor32 which is involved in the initiation of bone 
condensation.2 
 
Because both calcium phosphate and the aggregate mineral 
trioxide exhibit features that can help the bone formation process and 
that there are few data of the use of MTA (used isolated or in 
association with BCP) on bone formation, our work focused on the 
process of bone repair of defects in standardized calvaria of Wistar 
albino rats treated with BCP, MTA, or as a combination of the two. The 
main analytical techniques used herein were histological and 
immunohistochemistry analyses 
 
1. Materials and Methods 
 
This study was approved by the Research Ethics Committee for 
Animal Use (CEUA/PUCPR) under protocol #390/08. 80 animals 
(Wistar albine rats) with an average weight of 250 g were used in this 
study. The rats were randomly divided into four groups (n = 20 per 
group; 10 per group and period); two experiments were performed 
using two and eight week treatment periods. 
 
The procedure began by performing anesthesia on each animal 
by injecting xylazine 2% hydrochloride (8 mg/Kg of body weight; 
Anasedan®, Sespo Indústria e Comércio Ltda., Paulinia, São Paulo, 
Brazil) intraperitoneally in the presence of ketamine 5% hydrochloride 
(60 mg/Kg of body weight; Vetanarcol®, Laboratory König SA, 
Avellaneda, Argentina).Having confirmed the efficacy of the anesthetic, 
a total flap in the form of a "U" was made in the skull of each animal 
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using a #15 blade by exposing the surface of the calvaria bone. After 
opening up the flap, a circular osteotomy of 6 mm in diameter was 
made using a trephine drill attached to an angle using a dental 
micromotor in the presence of abundant cooling with a saline solution. 
Prior to the complete removal of the bone fragment, two small osseous 
incisions in the shape of an 'L' were performed in the antero-posterior 
skull direction so that the larger base of L coincided with the sagittal 
suture, which was taken to identify the location of the diameter of the 
circular defect. The incisions were made using a diamond cylindrical 
high-rotation drill. The amalgam was then applied to mark the center 
of the surgical wound.23 
 
After carefully removing the incised portion of the calvaria with 
the aid of a Molt dissector, the BCP was added to the wound of 20 
animals (Straumann® BoneCeramic, Institut Straumann AG, Basel, 
Switzerland) as per the instructions of the manufacturer, filling the 
entire calvaria cavity (up to the edge of the defect). In 20 other 
samples, the MTA (MTA - Angelus®, Angelus Industry of dental 
products S/A, Londrina, Paraná, Brazil) was applied according to the 
instructions of the manufacturer. The last group of 20 animals was 
treated with a 1:1 combination of BCP and the MTA in the similar 
manner as the other groups. The last group allowed for the formation 
of blood clots in the surgical wound, thus serving as a control in the 
experiment. In all the animals, the flap was sutured with isolated knots 
of mononylon 4.0, followed by the surgical procedure. For pain control, 
sodium dipyrone 500 mg (D-500, Pfizer/Fort Dodge Animal Health 
Ltda., Campinas, São Paulo, Brazil) was given during three days after 
the surgery until the day of euthanasia. Subsequently, the animals 
were sacrificed with a lethal dose of an anesthetic, and during the 
evaluation periods of 2 weeks (10 animals of each treated group and 
10 animals in the control group) and 8 weeks (using the same number 
of animals). 
 
Histological Development 
 
After performing euthanasia on the animals, the entire calvaria 
was carefully cut open and soft tissue was gently removed from the 
bone. All samples were stored in 10% formalin for mounting of 
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surgical pieces, and hen demineralized in 4.13% EDTA for a period of 
75 days.  
 
The material received a routine histological processing for 
paraffin inclusion, followed by the microtome sagittal incisions using an 
"L" type marking in rgw amalgam to determine the location of the 
larger diameter of wound with a 3 μm thick material on the two slides 
of each piece for a total of 160 slides. 
 
The slides were stained with Masson's trichrome and analyzed 
using an optical microscope with 40x magnification. 
 
Immunohistochemistry Processing 
 
For immunostaining, serial sections with a thickness of 3 μm 
thick were deparafinized in xylol at 60 ºC, and hydrated using various 
concentrations of alcohols (absolute, 95 %, and 80 %). After 
hydration, the specimens were submitted to antigenic recovery using a 
1% solution of trypsin (pH = 7.2) for 45 min at 37 °C in an oven. 
 
The slides containing the histological cuts were washed and then 
immersed in 3% hydrogen peroxide for 30 minutes to inhibit the 
activity of the endogenous peroxidase. 
 
After rinsing with distilled water, the specimens were immersed 
in a buffered saline solution (PBS, pH 7.4) to maintain constant 
chemical properties of the reaction. Next, sections were incubated 
overnight with the primary antibody anti-BMPR-1B (200 μg/ml; Santa 
Cruz Biotechnology, Inc., Santa Cruz, California, USA) using a 1:100 
factor dilution in PBS. To detect the primary antibodies, a universal 
streptavidin-biotin peroxidase kit (Diagnostic BioSystem, Fremont, 
California, USA) was used according to the instructions of the 
manufacturer. The immune reaction was monitored using a solution of 
tetrachloride diaminobenzidine (Diagnostic BioSystem, Fremont, 
California, USA). Within 2 minutes of administering the drug, a brown-
brownish precipitate confirmed the presence of the antigen. The 
specimens were counter-stained with Harris hematoxylin for 3 
minutes. 
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For the negative control, we used the poly clonal IgG isotope (2 
mg/ml; Abcam) for 10 minutes after incubation at room temperature 
as the primary antibody of each sample. Three slides were used for the 
incubation of each antibody. 
 
Analysis of the Images 
 
All specimen images were captured using a digital camera 
(Samsung, South Korea) coupled to a light microscope (Zeiss, 
Germany) using the original 200× magnification of each digital image 
with a resolution of 600 dpi. A virtual image of 117× 80 cm was 
produced, which made it impossible to catch all aspects of the defect 
in a single at the magnification used. Accordingly, a digital framework 
composed of the entire defect was then constructed by combining two 
smaller images. The resulting images were evaluated in terms of bone 
tissue deposition and blood vessels by consulting histological 
references. 
 
All histomorfometrical measurements were performed using 
Image Tool software 2.00 (Department of Dental Diagnostic Science at 
The University of Texas Health Science Center, San Antonio, Texas, 
USA). 
 
An image of 1-mm slide was used to calibrate all 
measurements. The histomorphometric data were counted manually 
and expressed as areas (mm2). The perimeters of the deposited 
histological bone matrix and osteoid tissue areas were carefully traced, 
all areas were computed into the total histological area. At the same 
time, the percentage of positive BMPR-1B protein was accounted by 
automation, following the protocol established by Di Cataldo et al 
20109. This automated counting allowed counting only the percentage 
of protein present in the whole defect; it is not possible to distinguish 
their specific immunostaining in cells or bone matrix. 
 
Statistical Analysis 
 
The data obtained were analyzed using the statistical software 
SPSS 18.0 for Windows (SPSS, Inc., Chicago, IL). Normality tests 
(Kolmogorov-Smirnov and Shapiro-Wilk) were performed to examine 
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the data distributions, whilst Levene's test was to examine the 
homogeneity of variance, also using twoway ANOVA (Group X Time) 
followed by Games-Howell test for multiple comparisons with a 
significance level of 5% (p < 0.05). 
 
2. RESULTS 
 
Histomorphometrical Analysis 
 
The group that presented the largest amount of osteoid tissue 
was the 8-week MTA sample (Figure1). This group also exhibited the 
best results with respect to the amount of bone tissue (Figure2.) 
formed due to immunostaining. The groups that exhibited the highest 
percentage of stained cells were the 2-week MTA and 2-week 
BCP+MTA samples, with no statistically significant difference observed 
between the two. We also observed a decrease in the amount of 
immunostained cells from 2 to 8 weeks for groups that were treated 
with the biomaterials. In the control group, an increase in the 
immunomarker concentration from 2 to 8 weeks was observed 
(Figure3.). 
 
Histological Analysis 
 
1. MTA 
 
At two weeks after the operation, it is possible to identify the 
presence of bone formation (figure 4A) concentrated at the edges of 
the surgical defect in areas contiguous to the original remaining bone. 
This area of the bone matrix formation was surrounded by osteoid 
tissue as well as areas of a significant amount of connective tissue. 
Very little mature bone was observed in the central region of the 
defect. This region was composed predominantly of granulation tissue 
wherein the richly vascularized osteoid formation was concentrated in 
the peripheral areas of the histological sections. 
 
At eight weeks (figure 4B) after the operation, greater 
deposition of bone matrix was observed in the areas adjacent to the 
remaining bone. The body of the defect was filled with a significant 
formation of osteoid tissue, surrounded by immature medullar tissue. 
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2. BCP 
 
In the bone repair of the surgical defects filled with BCP, 
discrete bone formation was observed on the margins of the artificially 
created surgical defect 2 weeks after the operation (figure 4C). The 
body of the defect was composed predominantly of dense vascularized 
connective tissue, resulting in negative images of exogenous material 
compatible with the particles of the biomaterial. A small amount of 
giant cells and a specific amount of osteoid tissue were also observed 
around the biomaterial. Eight weeks after the operation (figure 4D), 
the histological reparation process similar to that of the second week 
process was observed. In this case, however, a greater deposition of 
bone matrix on the edges of the defect and the osteoid matrix near 
the biomaterial were observed. 
 
3. BCP Combined With the MTA 
 
Two weeks after the operation, a histological healing picture, 
represented by the moderate quantity of osteoid tissue composing the 
major part of the defect was observed (figure 4E). At 8 weeks after 
the operation (figure 4F), the majority of the defect was still composed 
of osteoid tissue, which was identified by the intense deposition of 
bone matrix at the margins of the defect in the form of trabeculae that 
mimic intramembranous ossification. 
 
4. Control (CLOT) 
 
The control group showed a predominance of granulation tissue, 
along with a diffuse and moderate chronic inflammatory process. Little 
deposition of bone matrix was identified two weeks after operation in 
this group (figure 4G); however, areas of osteoid tissue were observed 
to be concentrated adjacent to the remaining bone tissue or in areas 
restricted to the body of the defect. At eight weeks after the operation 
(figure 4H), mild bone formation was identified; however, the foci of 
bone mineralization were only observed in the thin connective tissue. 
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Immunohistochemical Analysis 
 
All groups tested positive for the BMPR-1B antibody. The highest 
BMPR-1B content was identified as the 2-week MTA group (figure 5A). 
For this period of time, the immunostaining with BMPR-1B+ occupied 
nearly the entire area of the defect. In contrast, eight weeks after the 
operation (figure 5B), the percentage of positive markers decreased as 
the proportion of osteoid or bone matrix increased. Despite the 
numerical difference, the overall pattern of immunostaining of the two 
periods was similar, resulting in a clear identification of the protein 
both in osteoprogenitor cells and the surrounding extracellular matrix. 
 
A different result was observed for samples treated with BCP 
alone (figure 5C) and BCP associated with the MTA (figure 5E). In the 
group treated with BCP, the BMPR-1B+ areas were found in the 
extracellular fibrous matrix, with an intense deposition of dense and 
rough fibers mimicking areas of precortical collagen formation of 
compact bones, involving the grafted biomaterial (5D) . 
 
In BCP/MTA group, the immunostaining of the BMPR-1B was 
more intense and a greater percentage of immunostaining was 
observed in comparison to the group in which only the BCP was 
grafted, both after two (figure 5E) and eight weeks (figure 5F). The 
presence to BMPR-1B was identified in osteoprogenitor cells and 
neoformed bone trabeculae in the extracellular matrix. 
 
A smaller amount of cells and BMPR-1B+matrix was found in the 
control group after both two weeks (5G) and eight weeks (figure 5H). 
In the control group, the cells are arranged in the area adjacent to the 
remaining bone tissue or in isolated areas among the connective 
tissue. 
 
Statistical Results 
 
In order to compare if there was difference among mean values 
of the variables: area of new bone and area of osteoid tissue and % of 
immunostaining, according to groups (MTA, BCP, MTA+BCP or Control) 
and period of time (2 or 8 weeks), as n<30, it was initially tested the 
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normality of data in each treatment (group X time) using Kolmogorov 
Smirnov test, that indicated normal distribution for all variables in all 
treatments, once p>0.05. After that, the homogeinity of variances was 
tested among treatments for each variable using the Levene test that 
indicated heterogeneity of variances among treatments for all of the 
three variables as p<0.05. Following that, twoway ANOVA (GROUP x 
TIME) was used indicating the presence of difference among groups 
and period of time (p<0.05), where the observed power was > 0.99. 
So, the significance of results was finally demonstrated by Games-
Howell for multiple comparisons with a significate level of 5% 
(p<0.05). It was possible to observe that MTA group (8 weeks) 
showed the highest mean value of osteoid tissue mm2 (6.25 ± 0.30) 
against control (2 weeks) that showed the lowest mean value (1.92 ± 
0.30). When the area of new bone in mm2 was evaluated, again, MTA 
(8 weeks) showed the highest mean value (3.98±0.14) and control (2 
weeks) had the lowest mean value (1.04±0.13). The % of 
immunostaining had the highest mean value for MTA in 2 weeks 
(40.73±2.50) with similar results with BC+MTA at 2 weeks 
(40.30±1.81), and the lowest mean value was found in control group 
in 2 weeks (10.02±0.70). (Table.1; Figures .1, .2, .3). 
 
Discussion 
 
Several studies 7, 12, 19, 23, 30, 31 in the literature have described 
the tissue reactions, both in soft and hard tissues using the materials 
employed in this research; however, there are only a few works in the 
literature that compared the use of the MTA and the BCP in isolation or 
in association for the healing of standardized critical bone defects. 
 
This study aimed to investigate whether the association between 
the BCP and the MTA could bring some benefits for bone neoformation. 
The best results in terms of area of osteoid tissue formed (area of 
bone tissue formed) and the percentage of BMPR1B marking were 
observed for the MTA group. This may be due to the excellent 
biocompatibility of material and the ability of osteoblastic cells to 
connect and spread on its surface.24 
 
In addition to stimulating adhesion and cell proliferation18, the 
expression of alkaline phosphatase by fibroblasts,4 osteocalcin and 
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other interleukins by osteoblasts,22 MTA was able to induce a greater 
expression of the BMPR-1B receptor, which is important in the process 
of osteogenesis, being directly involved in the process of bone 
condensation.² 
 
If only the area of osteoid tissue formed is analyzed, it is 
possible to observe an increase of this parameter from the period of 2 
to 8 weeks in all groups; however, in groups BCP, MTA and BCP+MTA, 
the increase was more pronounced, giving evidence that the presence 
of these materials would have stimulated an increased formation of 
this tissue in the type of critical defect used in this study. These results 
differ from those found by Frota et al., 201113 who surveyed the use of 
beta tricalcium phosphate, a component of BCP, which did not induce 
the formation of osteoid tissues in the control group, only in the 
groups where the biomaterial was present. This effect may be due to 
the short evaluation time (7, 15 and 30 days). 
 
Still, if one was to compare the control group with the other 
groups, a greater area of osteoid tissue formed in groups in which the 
materials were implanted, providing further evidence for the 
effectiveness of osteoconductive materials used in these critical 
defects.13 
 
The groups that the highest formation of osteoid tissue was MTA 
and MTA+BCP. No significant difference was observed among all 
groups, except between the 8-week control and the 2-week MTA, as 
well as the 2-week MTA and 2-week BCP+MTA. These results 
demonstrate that in period of 2 weeks, MTA already exhibited a 
greater area of osteoid tissue the 8-week control sample. The MTA also 
exhibited more beneficial results than the BCP during the same period 
of evaluation. 
 
The area of the newly formed bone tissue increased in size from 
2 to 8 weeks for the BCP, MTA and BCP+ MTA groups, demonstrating 
that these materials would continue to stimulate the formation tissue 
during over this period of time. 
 
If we compare the control group with the other groups, a 
greater area of bone tissue formation is observed in the biomaterials 
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groups. The material with the best results regarding the formation of 
bone tissue was the MTA. At the same time, when MTA is associated 
with BCP, the amount of tissue formed was lower than with MTA alone 
for both the 2 and 8 week-periods. These results indicate that the 
combination of these materials does not lead to significant benefits. 
Perhaps the space occupied by the BCP particles, especially if the 
particles were slowly reabsorbed, complicates the process of repair. 
However, if we evaluated the bone repair over a longer period of time, 
perhaps we would observe a higher reabsorption of these particles and 
perhaps the results would be more similar. 
 
The BCP group when compared to the control group showed a 
greater amount of bone tissue formation, and these results were 
statistically significant. Our results corroborate the findings of 
Schwarz, et al., 2007 26 and Cordaro, et al., 2008,7 which reported 
microscopic evidence of bone formation in the presence of biphasic 
calcium phosphate. According to Fleckenstein, et al. 2006 12 some 
studies have found some evidence that the ceramic calcium phosphate 
may have osteoconductive properties5, 7, 27, while others have 
discovered that the material becomes encapsulated by connective 
tissue, without osteoconductive properties.12 
 
Do Nascimento, et al., 2008 11 revealed that the deposition of 
hard tissue on the MTA is related to sealing ability, biocompatibility, 
and alkaline pH; the presence of calcium and phosphate of ions in their 
formulation; and the ability to attract blast cells and promote a 
favorable environment for cementum formation. The author reported 
that the osteoconductive effect, stimulation of the proliferation and cell 
adhesion, stimulation of the expression of alkaline phosphatase by 
fibroblasts and osteocalcin and other interleukins by osteoblasts, are 
also characteristics related to this material. These findings may help to 
explain the higher area of the formation of osteoid tissue and bone in 
the MTA group and MTA+BCP observed in this work.  
 
According to Singhatanadgit, and Olsen. 201128 the endogenous 
signaling of BMPR1B is required initiate the differentiation of 
osteoblasts. Thus, we evaluated the percentage of stained cells for 
BMPR1B, and we observed an increase of this percentage in the 2-
week control group relative to the 8-week control group, suggesting 
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that the beginning of the ossification process in this group occurs 
during a later period in the absence of biomaterials. For the MTA and 
BCP+MTA groups, the percentage of stained cells was higher doe the 
2-week group than the 8-week group. This finding suggests that there 
was a decrease in the quantity of osteoprogenitor cells that had free 
receptors for BMPR1B, indicating that the phase of formation of bone 
matrix, with greater synthesis activity, occurred during this period 
prior in the control group. This result differs from the work of Maeda, 
et al. 201020 where different levels of BMPR were observed between 
the control group and the MTA group. While the findings of the present 
study confirm a positive effect of MTA, it is necessary to conduct a 
larger study on the mechanism of this material in bone tissue 
regeneration as well as that of BCP, which is already used in surgeries. 
Additionally, the assessment period of two and eight weeks is not 
enough to consider the possibility of re-absorption of BCP particles. 
 
Within the limits of the present study, it was possible to 
conclude that the defects treated with MTA exhibited the good results 
in relation to bone formation and that the use of the MTA study 
associated with the BCP did not provide any additional benefits. The 
BCP alone showed better results than the control, but the role of the 
BCP particles in the material need to be evaluated for longer periods of 
time. 
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Captions for Figures 
 
Figure 1. Graph showing the mean (95% confidence interval) of area of 
osteoidtissue (mm2) in each treatment and period of time. 
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Figure 2. Graph showing the mean (95% confidence interval) of area of new 
bone (mm2) in each treatment and period of time. 
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Figure 3. Graph showing the mean (95% confidence interval) of % of 
immunostaining in each treatment and period of time. 
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Figure 4. Reveal histological aspects for each group in all time period. 
Micrographs A and B demonstrate the reparative frame in the calvária treated 
with MTA on 2nd and 8th weeks post surgery respectively. Verify the 
granulation tissue (gt) and the new fone formation (arrow) in the group. 
Figures C and D show the group treated with BCP on 2nd and 8th week 
respectively. Verify the granulation tissue (gt) and BCP particles in all time 
period, however few new bone formation was verified in these groups. 
Micrographs E and F reveal the characteristics histological of regenerative 
development in the group BCP mixed to MTA. Verify the intensive bone 
deposition (Arrow) in these group on the 8th week (F) when compared to 
group treated only with BCP. Control group is demonstrated in the 
micrographs G and H, where may be seen the intensive granulation tissue in 
all time period analyzed. gt= granulation tissue, Arrow = bone tissue 
deposition. (All micrograph stained with Masson’s trichrome staining, original 
magnification 40x). 
 
  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
International Journal of Oral and Maxillofacial Surgery, Vol. 44, No. 4 (April 2015): pg. 535-542. DOI. This article is © 
Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not grant 
permission for this article to be further copied/distributed or hosted elsewhere without the express permission from 
Elsevier. 
22 
 
 
Figure 5. Shows the immunohistochemical positivity for BMPR1B (Brownish 
color) among the groups. A and B reveals the intensive presence of positive 
cells among the granulation tissue respectively on 2 and 8 week post surgery. 
Micrographs C and D show the groups treated with BCP. Verify the BMPR1B 
positivity in cells and fibers that compound the granulation tissue only 
surrounding the BCP particles both on 2nd and 8th week post surgery. 
Micrographs E and F reveal the intensive presence of BMPR1B in the group 
BCP mixed to MTA on 2nd and 8th week post surgery. Figures G and H 
demonstrate the positivity for control group. Verify the scarce positivity for 
BMPR1B, except on 8th week post surgery where the positivy was restrict to 
border of de defect (Original magnification 40x) 
